Market Announcement 23 November 2021 23 November 2021 Market Announcement 1 / 1 ASX Limited ASX Customer Service Centre 131 279 | Actinogen Medical Limited (ASX: ACW) – Trading Halt Description The securities of Actinogen Medical Limited (‘ACW’) will be placed in trading halt at the request of ACW, pending it releasing an announcement. Unless ASX decides otherwise, the securities will remain in trading halt until the earlier of the commencement of normal trading on Thursday, 25 November 2021 or when the announcement is released to the market. Issued by Alice Montefiore-King Adviser, Listings Compliance (Sydney) ACTINOGEN MEDICAL LIMITED TRADING AS ACTINOGEN MEDICAL ACN 086 778 476 ASX | ACW Suite 901, Level 9, 109 Pitt Street, Sydney NSW 2000 AUSTRALIA TELEPHONE +61 2 8964 7401 WEB 23 November 2021 Ms Alice Montefiore-King Adviser Listings ASX Compliance (Sydney) 20 Bridge Street SYDNEY, NSW 2000 By email: Request for a trading halt Actinogen Medical Limited ACN 086 778 476 (ASX: ACW) (the Company ), requests that the Company's securities be placed into trading halt with immediate effect. Pursuant to ASX Listing Rule 17.1, the Company requests the trading halt in order to finalise arrangements around a potential capital raise, which the Company is not in a position to announce to the market at present. We anticipate that the trading halt will be required until no later than 10.00 am AEDT on Thursday, 25 November 2021. An announcement will be made to the market prior to that time which will clarify the above. The Company is not aware of any reason why the trading halt should not be granted by ASX Limited. Please contact me should you have any questions. Yours sincerely Peter Webse Company Secretary Announcement authorised by the Board of Directors of Actinogen Medical
Information on this Website is provided for general information purposes only and is not a substitute for professional advice. ASX Information (including company announcements and prices) is delayed by at least 20 minutes. JSE Information (including company announcements and prices) is delayed by at least 15 minutes. Reliance on the information you access on or from this Website is solely at your own risk. We make no representation or warranty in relation to the future performance of the companies that appear on this Website. Investment in securities involves risk and you should obtain independent professional legal, financial, investment or company advice before acting on any of the information you access on this Website. Using, browsing or otherwise accessing this Website is subject to our Terms and Conditions and our Privacy Policy.

© 2021 Listcorp. ABN 60 166 140 307

Never miss news from Actinogen Medical Limited (ASX:ACW) when you join Listcorp.